LAYTON v. SMYTH

District Court, W.D. Pennsylvania·Decided July 16, 2021·No. 2:20-cv-00519·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF PENNSYLVANIA PITTSBURGH MAURICE A. LAYTON, ) ) ) Civil Action 2: 20-cv-0519 Plaintiff, ) ) Chief United States Magistrate Judge vs. ) Cynthia Reed Eddy ) DR. DENISE SMYTH, WILLIAM ) NICHOLSON, STEPHANIE WOOD, and ) ROBERT D. GILMORE ) ) Defendants. )

MEMORANDUM OPINION AND ORDER1 Plaintiff, Maurice A. Layton, is a prisoner in the custody of the Pennsylvania Department of Corrections currently confined at SCI-Huntington. The events giving rise to this lawsuit occurred while Plaintiff was confined at SCI-Greene. Plaintiff’s original complaint was filed on April 21, 2020. (ECF No. 3). Prior to service, Plaintiff filed an Amended Complaint on July 24, 2020. (ECF No. 18). In response to Defendants’ motions to dismiss the Amended Complaint, Plaintiff filed a Second Amended Complaint (“SAC”) (ECF No. 42), which supersedes the Amended Complaint. The SAC remains Plaintiff’s operative pleading. See Garrett v. Wexford Health, 938 F.3d 69, 82 (3d Cir. 2019) (“In general, an amended pleading supersedes the original pleading and renders the original pleading a nullity. Thus, the most recently filed amended complaint becomes the operative pleading.”) (internal citations omitted). For purposes of resolving the pending motions, the facts as alleged in the SAC are viewed in the light most favorable to Plaintiff, and liberally construed. Phillips v. County of Allegheny,

1 In accordance with the provisions of 28 U.S.C. § 636(b)(1), the parties have voluntarily consented to jurisdiction by a United States Magistrate Judge, including entry of final judgment. (ECF Nos. 23, 27, and 44). 515 F.3d 224, 231 (3d Cir. 2008); Haines v. Kerner, 404 U.S. 519, 520-521 (1972). Pro se pleadings, however “inartfully pleaded” must be held to “less stringent standards than formal pleadings drafted by lawyers.” Haines, 404 U.S. at 520-21. Because Plaintiff is a pro se litigant, this Court may consider facts and make inferences where it is appropriate.

Plaintiff was diagnosed with ulcerative colitis (“UC”) in 2008. Since that time, he has been prescribed Asacol 800 mg, twice a day. In February 2016, Plaintiff “arrived” at SCI-Greene. (SAC, ¶ 11). Beginning in June of 2017, Plaintiff began filing sick call complaints stating that he was not receiving appropriate medical treatment for, inter alia, abdominal pain and cramps, loss of weight, loss of appetite, and diarrhea. According to the SAC, Plaintiff notified Dr. Smyth, the medical director at SCI-Greene; William Nicholson and Stephanie Wood, both Correctional Health Care Administrators at SCI-Greene, and Robert D. Gilmore, the Superintendent at SCI- Greene, of his ongoing concerns regarding the lack of medical treatment for his serious medical needs. In early February 2018, Plaintiff began receiving a higher dose of Asacol and was informed

that Dr. Smyth had prescribed the new prescription. (Id. at ¶ 19). As a result of the “overdose” of Asacol, Plaintiff began experiencing a number of side effects, including dizziness, headaches, and fear of his life. (Id. at ¶ 20). On April 17, 2018, Plaintiff had a colonoscopy at Washington Health System. On May 9, 2018, he was seen by Dr. Kumar at SCI-Greene, who informed Plaintiff that his tests results were negative and he did not have UC. On May 25, 2018, Plaintiff filed a grievance questioning why he was continued on Asacol despite the results from the colonoscopy showing that he no longer had UC. Defendant Woods, in denying the grievance, responded that he had had a diagnosis of UC and the pathology reports indicated that his polyps were benign. From October 17, 2018, through January 9, 2019, Plaintiff submitted numerous sick call complaints stating he was experiencing constant abdominal pain and cramps. On January 30, 2019, Plaintiff filed a grievance again questioning why he was continued to be prescribed Asacol when he did not have UC and stating that he thought the Asacol was causing his pain. Defendant

Nicholson, in denying the grievance, responded: “You had a diagnosis and were being treated for (UC). The Asacol is ordered to control inflammation and was offered to you for that benefit.” “You claim that the medication has caused you significant injuries and you have addressed them. I see no indication that you stated you are having issues to any of the providers.” “You made no mention of the significant injuries that you suffered from taking the Asacol.” “If you wanted testing, you didn’t ask for it at that time.”

(Id. at ¶ 44) (quoted verbatim).

Approximately two weeks later, on February 15, 2019, Plaintiff’s prescription for Asacol was discontinued. Two days later, he wrote to Dr. Smyth asking why she had discontinued the Asacol prescription. Dr. Smyth responded on February 20, 2019, that “The Asacol was discontinued as per. GI recommendations if biopsies were negative, which they were. You need repeat colonoscopy in 1 year.” (Id. at ¶ 50). On March 6, 2019, Plaintiff filed a grievance complaining that for the past seven months he had been prescribed Tofranil, a psychiatric drug, which had caused “serious mental health and physical damages, suicidal thinking, depression, nervousness, confusion, and hallucinations. Plaintiff was never given any counseling or monitoring.” (Id. at ¶ 51). Nicholson, in denying the grievance, responded that Tofranil was an off-label use for treatment of UC and “if you would have asked, you could’ve been told.” (Id. at ¶ 52). Plaintiff alleges that the defendants were deliberately indifferent to his serious medical needs in violation of the Eighth and Fourteenth Amendments to the U.S. Constitution. He also contends that Dr. Smyth violated his “informed consent” and his right to refuse Tofranil, a psychiatric drug. (Id. at ¶ 64). All defendants are sued in their individual capacities. Defendants have filed motions to dismiss: Defendant Smyth at ECF No. 46 and Defendants Nicholson, Wood, and Gilmore at ECF No. 48, arguing that the SAC should be dismissed under Federal Rule of Civil Procedure 12(b)(6) for failure to state a claim.2 Plaintiff filed an omnibus

response at ECF 52. For the reasons that follow, the motions will be denied in part and granted in part as explained below. The Supreme Court of the United States has issued two decisions that pertain to the standard of review for failure to state a claim upon which relief could be granted. The Supreme Court held that a complaint must include factual allegations that “state a claim to relief that is plausible on its face.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (citing Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007)). “[W]ithout some factual allegation in the complaint, a claimant cannot satisfy the requirement that he or she provide not only ‘fair notice’ but also the ‘grounds’ on which the claim rests.” Phillips v. County of Allegheny, 515 F.3d 224, 232 (3d Cir.

2008). In determining whether a plaintiff has met this standard, a court must reject legal conclusions unsupported by factual allegations, “[t]hreadbare recitals of the elements of a cause of action, supported by mere conclusory statements;” “labels and conclusions;” and “ ‘naked

Free access — add to your briefcase to read the full text and ask questions with AI

LAYTON v. SMYTH, (W.D. Pa. 2021).

LAYTON v. SMYTH (LAYTON v. SMYTH) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Haines v. Kerner
404 U.S. 519 (Supreme Court, 1972)
Scheuer v. Rhodes
416 U.S. 232 (Supreme Court, 1974)
Graham v. Connor
490 U.S. 386 (Supreme Court, 1989)
Albright v. Oliver
510 U.S. 266 (Supreme Court, 1994)
County of Sacramento v. Lewis
523 U.S. 833 (Supreme Court, 1998)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Karen Malleus v. John George
641 F.3d 560 (Third Circuit, 2011)
Liggon-Redding v. Estate of Robert Sugarman
659 F.3d 258 (Third Circuit, 2011)
Phillips v. County of Allegheny
515 F.3d 224 (Third Circuit, 2008)
Brian Schmigel v. Miroslav Uchal
800 F.3d 113 (Third Circuit, 2015)
Kareem Garrett v. Wexford Health
938 F.3d 69 (Third Circuit, 2019)